• Aurora Cannabis completed a major expansion of its EU-GMP facility in Leuna, Germany, more than doubling expected annual flower output.
• Multi-million-dollar investment lifts domestic cultivation capacity in Germany, strengthening supply for the country’s fast-growing medical market.
• Site renamed Aurora Horizon, positioned as a core node in the group’s European manufacturing network to support broader regional demand growth.
• Expanded areas received an updated EU-GMP license, clearing production scale-up for compliant distribution across European markets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aurora Cannabis Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: TO66033) on October 08, 2026, and is solely responsible for the information contained therein.